Urinary acylcarnitines are altered in human kidney cancer

International Journal of Cancer, 04/20/2012

This study shows for the first time the value of a novel class of metabolites which may lead to new therapeutic approaches for cancer and may prove useful in cancer biomarker studies. Furthermore, these findings open up a new area of investigation into the metabolic basis of kidney cancer.

Print Article Summary Cat 2 CME Report